Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.47 |
| ▸ | TTR | P02766 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | DHFR | P00374 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ALB | P02768 | 1/20 | 0.47 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.47 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26974251 | 0.88 | AKR1C3 (0.54) | TTRKDM4EMEN1USP2ALDH1A1 | |
| SCHEMBL19912967 | 0.88 | PTGS2 (0.50) | PTGS2PTGS1AKR1C3AKR1C2AKR1B10 | |
| SCHEMBL16945883 | 0.86 | PTGS2 (0.46) | PTGS2PTGS1AKR1C3AKR1C2AKR1B10 | |
| SCHEMBL10304724 | 0.84 | PTGS2 (0.47) | PTGS2PTGS1ABL1 | |
| SCHEMBL27115962 | 0.84 | PTGS2 (0.47) | PTGS2PTGS1AKR1C3AKR1C2AKR1B10 | |
| SCHEMBL16728066 | 0.83 | PTGS2 (0.51) | PTGS2TTRKDM4EMEN1USP2 | |
| SCHEMBL2760398 | 0.83 | TTR (0.59) | TTRKDM4EMEN1USP2ALDH1A1 | |
| SCHEMBL13368889 | 0.83 | TTR (0.48) | PTGS2TTRKDM4EMEN1USP2 | |
| SCHEMBL802682 | 0.82 | PTGS2 (0.46) | PTGS2PTGS1AKR1C3AKR1C2AKR1B10 | |
| SCHEMBL25840018 | 0.81 | PTGS2 (0.51) | PTGS2ALDH1A1PTGS1AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2182002-B1 | Novel compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC (KR) | 2012-07-04 | — | — | EP | disclosed |
| EP-2066150-B1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC (KR) | 2010-05-26 | — | — | EP | disclosed |
| EP-2182002-A1 | Novel compounds for electronic material and organic electronic device using the same | Gracel Display Inc. (KR) | 2010-05-05 | — | — | EP | disclosed |
| US-20100102710-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-04-29 | — | — | US | disclosed |
| US-20090261714-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-22 | — | — | US | disclosed |
| EP-2098532-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-09-09 | — | — | EP | disclosed |
| EP-2085450-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-08-05 | — | — | EP | disclosed |
| US-20090184629-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-23 | — | — | US | disclosed |
| US-20090179555-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-16 | — | — | US | disclosed |
| US-20090174316-A1 | Novel red electroluminescent compounds and organi electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-07-09 | — | — | US | disclosed |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-06-18 | — | — | US | disclosed |
| EP-2062959-A2 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-27 | — | — | EP | disclosed |
| EP-2055710-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-05-06 | — | — | EP | disclosed |
| EP-2053112-A2 | Novel red electroluminescent compounds and organic electroluminescent device using the same | Gracel Display Inc. (KR) | 2009-04-29 | — | — | EP | disclosed |
| EP-1986633-A2 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | Summit Corporation Plc (GB) | 2008-11-05 | — | — | EP | disclosed |
| WO-2007091106-A2 | TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | SUMMIT CORPORATION PLC (GB) | 2007-08-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090261714-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | AOX1, ODC1, LEF1 | PTGS2 1889/4885TTR 3736/4885KDM4E 2044/4885 |
| US-20090174316-A1 | Novel red electroluminescent compounds and organi electroluminescent device using the same | ALPI, IK, ALDH1A2 | PTGS2 3102/4885TTR 3437/4885KDM4E 2833/4885 |
| US-20090153037-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | NDUFS2, ALDH1A2, ODC1 | PTGS2 2276/4885TTR 3448/4885KDM4E 1792/4885 |
| US-20090184629-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | IK, TYR, EYA2 | PTGS2 3970/4885TTR 2099/4885KDM4E 1716/4885 |
| US-20100102710-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ODC1, AOX1, OR10J3 | PTGS2 2068/4885TTR 3305/4885KDM4E 1974/4885 |
| US-20090179555-A1 | Novel red electroluminescent compounds and organic electroluminescent device using the same | NDUFS2, ALDH1A2, ODC1 | PTGS2 2276/4885TTR 3448/4885KDM4E 1792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.